– Generated Record Quarterly and Full-Year Net Revenue of $149.7 Million and $566.8 Million – – Achieved Quarterly and Full-Year GAAP Net Income of $31.9 Million and $48.2 Million – .
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, February 22nd. Analysts expect Collegium Pharmaceutical to post earnings of $1.27 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Collegium […]
Third Avenue Management, an investment management company based in New York City, released its “Small-Cap Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In 2023 the fund returned 21.88% compared to a 14.65% return for the Russell 2000 Value Index. In Q4 the fund returned 9.38% versus 15.26% […]
Scott Dreyer, EVP & Chief Commercial Officer of Collegium Pharmaceutical Inc (NASDAQ:COLL), has sold 23,560 shares of the company on January 16, 2024, according to a recent SEC Filing.